Related references
Note: Only part of the references are listed.Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305
Jacqueline A. French et al.
EPILEPSIA (2013)
Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures
Ivan Rektor
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Novel treatment options for epilepsy: Focus on perampanel
V. Franco et al.
PHARMACOLOGICAL RESEARCH (2013)
Tolerability and safety of perampanel: two randomized dose-escalation studies
G. L. Krauss et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus
Laura Ceolin et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304
Jacqueline A. French et al.
NEUROLOGY (2012)
Randomized phase III study 306 Adjunctive perampanel for refractory partial-onset seizures
G. L. Krauss et al.
NEUROLOGY (2012)
Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy
Takahisa Hanada et al.
EPILEPSIA (2011)
The pharmacological treatment of epilepsy in adults
Emilio Perucca et al.
LANCET NEUROLOGY (2011)
Antiepileptic Drug Interactions - Principles and Clinical Implications
Svein I. Johannessen et al.
Current Neuropharmacology (2010)
Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Philip N. Patsalos et al.
EPILEPSIA (2008)
Refractory epilepsy: Clinical overview
Jacqueline A. French
EPILEPSIA (2007)
Share Paper
